Less than a month after filing for Chapter 11 bankruptcy protection for the second time in a year, craft retailer JOANN is ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Agios Pharmaceuticals reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of -$1.44 compared to the forecast of -$1.68. The company also ...

ATDS Data443 Risk Mitigation, Inc.